OPKO Health, Inc. (OPK)
USD 1.5
(-3.23%)
USD 1.5
(-3.23%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 222.03 Million USD | 5.53% |
| 2022 | 210.4 Million USD | 11.97% |
| 2021 | 187.9 Million USD | -15.36% |
| 2020 | 222 Million USD | 5.11% |
| 2019 | 211.2 Million USD | 568.35% |
| 2018 | 31.6 Million USD | -77.85% |
| 2017 | 142.66 Million USD | 226.46% |
| 2016 | 43.7 Million USD | -11.54% |
| 2015 | 49.4 Million USD | -62.43% |
| 2014 | 131.5 Million USD | -38.89% |
| 2013 | 215.18 Million USD | 4078.29% |
| 2012 | 5.15 Million USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 15.34 Million USD | 29.27% |
| 2008 | 11.86 Million USD | 1.52% |
| 2007 | 11.68 Million USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 108 Thousand USD | -46.53% |
| 2001 | 202 Thousand USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 327.14 Million USD | 47.34% |
| 2024 Q2 | 179.61 Million USD | -45.1% |
| 2023 Q2 | 252.89 Million USD | 19.68% |
| 2023 Q1 | 211.3 Million USD | 0.43% |
| 2023 Q4 | 222.03 Million USD | 4.09% |
| 2023 Q3 | 213.3 Million USD | -15.66% |
| 2023 FY | 222.03 Million USD | 5.53% |
| 2022 Q2 | 248.62 Million USD | 0.27% |
| 2022 FY | 210.4 Million USD | 11.97% |
| 2022 Q3 | 184.14 Million USD | -25.94% |
| 2022 Q4 | 210.4 Million USD | 14.26% |
| 2022 Q1 | 247.95 Million USD | 31.96% |
| 2021 FY | 187.9 Million USD | -15.36% |
| 2021 Q1 | 263 Million USD | 18.47% |
| 2021 Q2 | 220.33 Million USD | -16.23% |
| 2021 Q3 | 217.77 Million USD | -1.16% |
| 2021 Q4 | 187.9 Million USD | -13.72% |
| 2020 Q4 | 222 Million USD | -12.59% |
| 2020 Q3 | 253.96 Million USD | -16.42% |
| 2020 Q2 | 303.86 Million USD | 5.21% |
| 2020 Q1 | 288.81 Million USD | 36.75% |
| 2020 FY | 222 Million USD | 5.11% |
| 2019 Q3 | 291.07 Million USD | -2.03% |
| 2019 FY | 211.2 Million USD | 568.35% |
| 2019 Q2 | 297.1 Million USD | 45.85% |
| 2019 Q1 | 203.7 Million USD | 544.62% |
| 2019 Q4 | 211.2 Million USD | -27.44% |
| 2018 Q3 | 167.95 Million USD | -1.07% |
| 2018 FY | 31.6 Million USD | -77.85% |
| 2018 Q4 | 31.6 Million USD | -81.19% |
| 2018 Q2 | 169.77 Million USD | 99.97% |
| 2018 Q1 | 84.9 Million USD | -40.49% |
| 2017 Q4 | 142.66 Million USD | 8.49% |
| 2017 FY | 142.66 Million USD | 226.46% |
| 2017 Q1 | 88.47 Million USD | 102.45% |
| 2017 Q2 | 114.5 Million USD | 29.43% |
| 2017 Q3 | 131.49 Million USD | 14.84% |
| 2016 Q1 | 133.17 Million USD | 169.59% |
| 2016 FY | 43.7 Million USD | -11.54% |
| 2016 Q4 | 43.7 Million USD | -15.15% |
| 2016 Q3 | 51.5 Million USD | -45.02% |
| 2016 Q2 | 93.67 Million USD | -29.66% |
| 2015 Q4 | 49.4 Million USD | -11.88% |
| 2015 Q2 | 111.35 Million USD | 2.29% |
| 2015 FY | 49.4 Million USD | -62.43% |
| 2015 Q1 | 108.85 Million USD | -17.22% |
| 2015 Q3 | 56.06 Million USD | -49.65% |
| 2014 Q4 | 131.5 Million USD | 11.91% |
| 2014 Q1 | 227.9 Million USD | 5.91% |
| 2014 FY | 131.5 Million USD | -38.89% |
| 2014 Q2 | 119.31 Million USD | -47.65% |
| 2014 Q3 | 117.51 Million USD | -1.51% |
| 2013 Q2 | 192.16 Million USD | -3.98% |
| 2013 FY | 215.18 Million USD | 4078.29% |
| 2013 Q4 | 215.18 Million USD | 1.37% |
| 2013 Q3 | 212.26 Million USD | 10.46% |
| 2013 Q1 | 200.12 Million USD | 3785.96% |
| 2012 Q3 | 3.95 Million USD | -83.79% |
| 2012 Q4 | 5.15 Million USD | 30.25% |
| 2012 Q1 | - USD | 0.0% |
| 2012 FY | 5.15 Million USD | 0.0% |
| 2012 Q2 | 24.38 Million USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | -100.0% |
| 2010 FY | - USD | -100.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 FY | 15.34 Million USD | 29.27% |
| 2009 Q1 | 14.08 Million USD | 18.72% |
| 2009 Q3 | 14.91 Million USD | 2.88% |
| 2009 Q4 | 15.34 Million USD | 2.88% |
| 2009 Q2 | 14.49 Million USD | 2.87% |
| 2008 Q1 | 13.42 Million USD | 14.82% |
| 2008 Q3 | 11.83 Million USD | 0.43% |
| 2008 Q4 | 11.86 Million USD | 0.25% |
| 2008 FY | 11.86 Million USD | 1.52% |
| 2008 Q2 | 11.78 Million USD | -12.18% |
| 2007 Q2 | 3.92 Million USD | -18.35% |
| 2007 Q3 | 7.63 Million USD | 94.45% |
| 2007 Q1 | 4.81 Million USD | 0.0% |
| 2007 Q4 | 11.68 Million USD | 53.04% |
| 2007 FY | 11.68 Million USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2003 Q1 | 84 Thousand USD | -22.22% |
| 2003 Q2 | 59 Thousand USD | -29.76% |
| 2003 Q3 | 34 Thousand USD | -42.37% |
| 2003 Q4 | - USD | -100.0% |
| 2003 FY | - USD | -100.0% |
| 2002 Q2 | 148 Thousand USD | -26.73% |
| 2002 Q3 | 79 Thousand USD | -46.62% |
| 2002 Q4 | 108 Thousand USD | 36.71% |
| 2002 FY | 108 Thousand USD | -46.53% |
| 2002 Q1 | 202 Thousand USD | 0.0% |
| 2001 Q3 | - USD | -100.0% |
| 2001 Q4 | 202 Thousand USD | 0.0% |
| 2001 FY | 202 Thousand USD | 0.0% |
| 2001 Q1 | 750 Thousand USD | 0.0% |
| 2001 Q2 | 687 Thousand USD | -8.4% |
| 2000 FY | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q2 | - USD | -100.0% |
| 1999 Q1 | 1 Million USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| bioAffinity Technologies, Inc. | 1.11 Million USD | -19751.618% |
| Aspira Women's Health Inc. | 1.43 Million USD | -15426.853% |
| Castle Biosciences, Inc. | 14.19 Million USD | -1463.84% |
| Exact Sciences Corporation | 2.47 Billion USD | 91.03% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | 64.354% |
| Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -272923.954% |
| iSpecimen Inc. | 29.13 Thousand USD | -762117.645% |
| Standard BioTools Inc. | 3.98 Million USD | -5474.542% |
| Inotiv, Inc. | 399.4 Million USD | 44.409% |
| Psychemedics Corporation | 945 Thousand USD | -23395.661% |
| Prenetics Global Limited | 867.21 Thousand USD | -25503.109% |
| RadNet, Inc. | 812.06 Million USD | 72.658% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -19291.616% |
| Neuronetics, Inc. | 59.28 Million USD | -274.532% |
| OpGen, Inc. | 2.02 Million USD | -10882.996% |
| Exagen Inc. | 19.23 Million USD | -1054.563% |
| Bionano Genomics, Inc. | 7.17 Million USD | -2994.551% |
| CareDx, Inc | 28.27 Million USD | -685.183% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 79.17 Million USD | -180.442% |
| Guardant Health, Inc. | 1.13 Billion USD | 80.523% |
| Biodesix, Inc. | 35.22 Million USD | -530.331% |
| BioNexus Gene Lab Corp. | 98.76 Thousand USD | -224714.961% |
| Precipio, Inc. | 106 Thousand USD | -209366.038% |
| Natera, Inc. | 282.94 Million USD | 21.528% |
| Fulgent Genetics, Inc. | 10.11 Million USD | -2095.965% |
| Sera Prognostics, Inc. | 840 Thousand USD | -26332.619% |
| 23andMe Holding Co. | 67.84 Million USD | -227.267% |
| Personalis, Inc. | 1.23 Million USD | -17893.031% |
| Aclaris Therapeutics, Inc. | 3.07 Million USD | -7122.967% |
| Applied DNA Sciences, Inc. | 739.16 Thousand USD | -29938.611% |
| T2 Biosystems, Inc. | 6.59 Million USD | -3265.171% |
| Neogen Corporation | 888.39 Million USD | 75.007% |
| Myriad Genetics, Inc. | 130.9 Million USD | -69.621% |
| ICON Public Limited Company | 3.66 Billion USD | 93.942% |
| NeoGenomics, Inc. | 606.06 Million USD | 63.365% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -19291.616% |
| MDxHealth SA | 35.56 Million USD | -524.322% |
| Prenetics Global Limited | 867.21 Thousand USD | -25503.109% |
| Illumina, Inc. | 1.48 Billion USD | 85.088% |
| DarioHealth Corp. | 24.59 Million USD | -802.908% |
| ENDRA Life Sciences Inc. | 192.06 Thousand USD | -115505.377% |
| Medpace Holdings, Inc. | 142.12 Million USD | -56.228% |
| Mainz Biomed B.V. | 2.19 Million USD | -10011.349% |
| Trinity Biotech plc | 54.65 Million USD | -306.276% |
| Sotera Health Company | 2.22 Billion USD | 90.015% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | -19751.618% |